SiteOne Therapeutics competitorsClear all

SiteOne Therapeutics's top competitors include Dermala, Peptilogics, Eternygen and Biohaven Pharmaceutical.
SiteOne Therapeutics
SiteOne Therapeutics
SiteOne Therapeutics is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids
Dermala
Dermala
Dermala, a spinout from the University of California San Diego, is utilizing the human microbiome to develop novel, natural, safe, and effective products to treat chronic skin diseases and enhance skin health.
Peptilogics
Peptilogics
Peptilogics is an early stage biotech company developing a breakthrough technology platform in the antimicrobial segment.
Eternygen
Eternygen
Eternygen is focusing on research and development of innovative drugs using a network of renowned scientists and contract research organizations.
Biohaven Pharmaceutical
Biohaven Pharmaceutical
Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.
Founding Date
Founding Date
2010
Founding Date
2014
Founding Date
2013
Founding Date
2012
Founding Date
2014
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Bozeman, US HQ
Bozeman, US
Locations
San Diego, US HQ
Locations
Pittsburgh, US HQ
Locations
Berlin, DE HQ
Berlin, DE
Edinburgh, GB
Locations
New Haven, US HQ
Employees
Employees
N/A
Employees
9
Employees
1011% increase
Employees
6
Employees
8051% increase
Twitter followers
Twitter followers
N/A
Twitter followers
665
Twitter followers
202
Twitter followers
N/A
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
309822
Alexa Website Rank
244327
Alexa Website Rank
N/A
Alexa Website Rank
231538

Funding

Latest funding round
Latest funding round
$ 15m (about 4 years ago)
Latest funding round
$ 1m (almost 3 years ago)
Latest funding round
$ 35.4m (3 months ago)
Latest funding round
$ 8.4m (about 4 years ago)
Latest funding round
$ 80m (over 4 years ago)
Total funding raised
Total funding raised
$ 17.8m
Total funding raised
$ 1m
Total funding raised
$ 41.3m
Total funding raised
$ 8.4m
Total funding raised
$ 80m
For sources of this data, please see the company profile

View company profiles

Dermala
HQ
San Diego, US
Employees
9

Dermala, a spinout from the University of California San Diego, is utilizing the human microbiome to develop novel, natural, safe, and effective products to treat chronic skin diseases and enhance skin health.

View company
Peptilogics
HQ
Pittsburgh, US
Employees
10↑ 11% increase

Peptilogics is an early stage biotech company developing a breakthrough technology platform in the antimicrobial segment.

View company
Eternygen
HQ
Berlin, DE
Employees
6

Eternygen is focusing on research and development of innovative drugs using a network of renowned scientists and contract research organizations.

View company
Biohaven Pharmaceutical
HQ
New Haven, US
Employees
805↑ 1% increase

Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.

View company